SCOPUS 정보 검색 플랫폼

Bulletin of Experimental Biology and Medicine

Volumn 151, Issue 6, 2011, Pages 741-746

Relationship between CYP2E1 polymorphism and increase of ALT activity during therapy of patients with pulmonary tuberculosis

(6) Kudryashov, A V a Vavilin, V A a Kolpakova, T A b Mutaykhan, Zh b Krasnov, V A b Lyakhovich, V V a

a INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS (Russian Federation)

b Federal Agency for Health Care and Social Development (Russian Federation)

Author keywords

alanine aminotransferase; cytochrome P450 2E1; genetic polymorphism; hepatotoxicity; tuberculosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CYP2E1 GENE; DRUG DOSE REGIMEN; DRUG RESPONSE; ENZYME ACTIVITY; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; LIVER TOXICITY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; SIDE EFFECT; WILD TYPE;

ALANINE TRANSAMINASE; ANTITUBERCULAR AGENTS; CYTOCHROME P-450 CYP2E1; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; TUBERCULOSIS, PULMONARY;

EID: 80755186916 PISSN: 00074888 EISSN: 15738221 Source Type: Journal
DOI: 10.1007/s10517-011-1430-9 Document Type: Article

Times cited : (3)

References (13)

1
- 34250637214
- 17486761 1:STN:280:DC%2BD2s3nslGmug%3D%3D
- AV Marusin VA Stepanov MG Spiridonova, et al. 2007 Genetika 43 3 409 416 17486761 1:STN:280:DC%2BD2s3nslGmug%3D%3D
- (2007) Genetika , vol.43 , Issue.3 , pp. 409-416
- Marusin, A.V.¹ Stepanov, V.A.² Spiridonova, M.G.³

2
- 78851470285
- 21261721 10.1111/j.1440-1746.2010.06355.x 1:CAS:528:DC%2BC3MXjt1SqtL4%3D
- PD Bose MP Sarma S Medhi, et al. 2011 J. Gastroenterol. Hepatol. 26 2 312 318 21261721 10.1111/j.1440-1746.2010.06355.x 1:CAS:528:DC%2BC3MXjt1SqtL4%3D
- (2011) J. Gastroenterol. Hepatol. , vol.26 , Issue.2 , pp. 312-318
- Bose, P.D.¹ Sarma, M.P.² Medhi, S.³

3
- 61349192330
- 10.1093/toxsci/kfn269 1:CAS:528:DC%2BD1MXit1KksLw%3D
- N Duale T Bjellaas J Alexander, et al. 2009 Toxicol. Sc. 108 1 90 99 10.1093/toxsci/kfn269 1:CAS:528:DC%2BD1MXit1KksLw%3D
- (2009) Toxicol. Sc. , vol.108 , Issue.1 , pp. 90-99
- Duale, N.¹ Bjellaas, T.² Alexander, J.³

4
- 0033600711
- Structural and functional characterization of the 5'-flanking region of the rat and human cytochrome P450 2E1 genes: Identification of a polymorphic repeat in the human gene
- DOI 10.1006/bbrc.1999.1362
- Y Hu J Hakkola M Oscarson M Ingelman-Sundberg 1999 Biochem. Biophys. Res. Commun. 263 2 286 293 10491286 10.1006/bbrc.1999.1362 1:CAS:528: DyaK1MXlvFantro%3D (Pubitemid 29467189)
- (1999) Biochemical and Biophysical Research Communications , vol.263 , Issue.2 , pp. 286-293
- Hu, Y.¹ Hakkola, J.² Oscarson, M.³ Ingelman-Sundberg, M.⁴

5
- 34249304028
- Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-inducedliver injury
- DOI 10.1517/17425255.3.1.1
- YS Huang 2007 Expert. Opin. Drug Metab. Toxicol. 3 1 1 8 17269890 10.1517/17425255.3.1.1 (Pubitemid 47307453)
- (2007) Expert Opinion on Drug Metabolism and Toxicology , vol.3 , Issue.1 , pp. 1-8
- Huang, Y.-S.¹

6
- 0037380862
- Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis
- DOI 10.1053/jhep.2003.50144
- YS Huang HD Chern WF Su, et al. 2003 Hepatology 37 4 924 930 12668988 10.1053/jhep.2003.50144 1:CAS:528:DC%2BD3sXjt1Wlurc%3D (Pubitemid 36397406)
- (2003) Hepatology , vol.37 , Issue.4 , pp. 924-930
- Huang, Y.-S.¹ Chern, H.-D.² Su, W.-J.³ Wu, J.-C.⁴ Chang, S.-C.⁵ Chiang, C.-H.⁶ Chang, F.-Y.⁷ Lee, S.-D.⁸

7
- 16044367886
- 8877060 1:CAS:528:DyaK28XmtF2ksr4%3D
- MT Landi C Zocchetti I Bernucci, et al. 1996 Cancer Epidemiol. Biomarkers Prev. 5 9 693 698 8877060 1:CAS:528:DyaK28XmtF2ksr4%3D
- (1996) Cancer Epidemiol. Biomarkers Prev. , vol.5 , Issue.9 , pp. 693-698
- Landi, M.T.¹ Zocchetti, C.² Bernucci, I.³

8
- 0031878156
- 1:CAS:528:DyaK1cXls1Sjt7k%3D
- A Lum L Le Marchand 1998 Ibid. 7 8 719 724 1:CAS:528:DyaK1cXls1Sjt7k%3D
- (1998) Cancer Epidemiol. Biomarkers Prev. , vol.7 , Issue.8 , pp. 719-724
- Lum, A.¹ Le Marchand, L.²

9
- 47749150312
- Human N-acetyltransferases and drug-induced hepatotoxicity
- DOI 10.2174/138920008784892047
- SI Makarova 2008 Curr. Drug Metab. 9 6 538 545 18680474 10.2174/138920008784892047 1:CAS:528:DC%2BD1cXpslOjsbs%3D (Pubitemid 352025185)
- (2008) Current Drug Metabolism , vol.9 , Issue.6 , pp. 538-545
- Makarova, S.I.¹

10
- 75749113367
- 20183527 1:CAS:528:DC%2BD1MXhtlCktb%2FO
- P Neafsey G Ginsberg D Hattis, et al. 2009 J. Toxicol. Environ. Health B. Crit. Rev. 12 5-6 362 388 20183527 1:CAS:528:DC%2BD1MXhtlCktb%2FO
- (2009) J. Toxicol. Environ. Health B. Crit. Rev. , vol.12 , Issue.56 , pp. 362-388
- Neafsey, P.¹ Ginsberg, G.² Hattis, D.³

11
- 0345866797
- Suppression of Cytochrome P450 2E1 Promoter Activity by Interferon-γ and Loss of Response Due to the -71G>T Nucleotide Polymorphism of the CYP2E1*7B Allele
- DOI 10.1124/jpet.103.057208
- LO Qiu MW Linder DM Antonio-Green R Valdes Jr 2004 J. Pharmacol. Exp. Ther. 308 1 284 288 14566010 10.1124/jpet.103.057208 1:CAS:528: DC%2BD2cXmsFensA%3D%3D (Pubitemid 38090729)
- (2004) Journal of Pharmacology and Experimental Therapeutics , vol.308 , Issue.1 , pp. 284-288
- Qiu, L.O.¹ Linder, M.W.² Antonino-Green, D.M.³ Valdes Jr., R.⁴

12
- 42449142373
- Pharmacogenomics of anti-TB drugs-related hepatotoxicity
- DOI 10.2217/14622416.9.3.311
- PD Roy M Majumder B Roy 2008 Pharmacogenomics 9 3 311 321 18303967 10.2217/14622416.9.3.311 (Pubitemid 351803934)
- (2008) Pharmacogenomics , vol.9 , Issue.3 , pp. 311-321
- Roy, P.D.¹ Majumder, M.² Roy, B.³

13
- 39649102578
- 18254208 1:CAS:528:DC%2BD1cXkvVGhug%3D%3D
- V Tayal BS Kalra S Agarwal, et al. 2007 Indian J. Exp. Biol. 45 12 1031 1036 18254208 1:CAS:528:DC%2BD1cXkvVGhug%3D%3D
- (2007) Indian J. Exp. Biol. , vol.45 , Issue.12 , pp. 1031-1036
- Tayal, V.¹ Kalra, B.S.² Agarwal, S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.